The positivity of the antibody anti-SS-A/Ro is associated with clinical SLE manifestations, such as leukopenia, subacute cutaneous lupus, neonatal lupus, and congenital heart block [21,22,23]. This evidence concerns the gene CALR and neonatal lupus erythematosus.